Inspira Technologies Oxy B.H.N. Ltd. (IINN): Market Cap to Revenue

Symbol and logo of brand Inspira Technologies Oxy B.H.N. Ltd (IINN)

Inspira Technologies Oxy produces smart oxygenation devices featuring AI-driven perfusion control. This P/S ratio chart illustrates the business valuation relative to sales, where the indicator stands at 56.30. The company's stability is underpinned by the constant demand for respiratory support. Growth prospects are based on the implementation of non-intubated artificial respiration systems, which are transforming intensive care medicine.

IINN Inspira Technologies Oxy B.H.N. Ltd P/S Multiple (10/03/2025 - 05/20/2026)

Analytical breakdowns for Inspira Technologies Oxy B.H.N. Ltd. (IINN)

General company analysis:IINN Inspira Technologies Oxy
Core merchandise of Inspira Technologies

When screening issuer reliability, the P/S ratio serves as a key filter for assessing market value relative to generated revenue. The multiple is calculated as the ratio of market capitalization to annual sales volume, measuring the premium the market is willing to pay per unit of revenue. For Inspira Technologies Oxy (IINN), given its pre-revenue stage and focus on a single oxygenation device, this metric reflects speculative expectations of future breakthroughs. Analyzing the price-to-sales multiple history allows for the timely detection of pricing anomalies before official reports are published.

Competitors of Inspira Technologies Oxy

DXCM (DexCom Inc) - Market Capitalization-to-Revenue Ratio|P/S Multiple PEN (penumbrainc.com)|NOVT - Market Cap to Revenue|Haemonetics - P/S Multiple|Price to Sales Inspire Medical Systems|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Medical) - P/S Multiple|InMode Corp (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics, Inc. SRDX|P/S Multiple SENS (senseonics.com)|P/S Multiple NeuroPace Inc NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|Outset Medical Corp (OM) - Price-to-Revenue Ratio|SmartVest - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR Inc) - P/S Multiple|Price to Sales AVITA Medical Inc. RCEL|Price-to-Revenue Ratio Profound Medical (PROF)|Baird Medical Corp (BDMD) - Price-to-Revenue Multiple|EDAP TMS SA - Market Cap to Revenue|P/S Multiple Bovie Medical APYX|IceCure Medical Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx LUNG|TELA Bio (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corp.)|Price-to-Revenue Ratio sensushealthcare.com|Market Cap to Revenue Zynex, Inc. (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|SeaStar Medical - Market Cap to Revenue|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|beyondair.net - Market Cap to Sales Volume|Profusa Inc (PFSA) - Price-to-Revenue Ratio|SSKN - Price-to-Revenue Coefficient|Price-to-Revenue Ratio GlucoTrack|P/S Multiple NanoVibronix Inc.|Price-to-Revenue Ratio Venus Concept (VERO)|Market Cap to Revenue Nuwellis, Inc. NUWE|P/S Multiple AEMD (Aethlon Medical, Inc.)|ASXC: Market Cap to Revenue Ratio|Avinger Inc. - P/S Multiple|Price-to-Revenue Coefficient BioSig Technologies, Inc BSGM|CUTR: P/S Multiple|Know Labs, Inc. (KNW) - P/S Multiple|Price-to-Revenue Ratio Inari Medical Inc|Market Cap to Revenue Nevro Corp (NVRO)|Market Cap to Revenue RSLS (ReShape Lifesciences, Inc.)|P/S Multiple Silk Road Medical Inc. (SILK)